Last updated on January 2017

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)


Brief description of study

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)

Detailed Study Description

Receive Redovapagon or Placebo for the treatment of nocturia

Clinical Study Identifier: TX147204

Contact Investigators or Research Sites near you

Start Over

Carlos Colunga, CRC

Clinical Research of South Florida
Coral Gables, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.